Price $3.20 |
Market Cap
119.6M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
-
|
P/S
15.45
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-29.8K
|
FCF
-0.6
|
|
Op. Margin
-483.80%
|
Net Margin
-644.30%
|
ROE
174.50%
|
ROI
-5.90%
|
|
ROA
-63.40%
|
EPS Growth
-16.30%
|
Current Ratio
4.6
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Endo International PLC (ENDP) | $6.31 | - | - | 1.27B | Strong Buy |
| Chembio Diagnostics Inc (CEMI) | $9.30 | - | - | 111.9M | Strong Buy |
| Kalvista Pharmaceuticals Inc (KALV) | $8.95 | - | - | 95.7M | Strong Buy |
| MacroGenics Inc (MGNX) | $22.68 | - | - | 952.9M | Strong Buy |
| Mannatech, Inc. (MTEX) | $20.70 | - | 2.50% | 54.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
